相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice
Farida El Gaamouch et al.
MOLECULAR NEURODEGENERATION (2020)
Risk factors for progression of age-related macular degeneration
Thomas J. Heesterbeek et al.
OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2020)
CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
Lukmanee Tradtrantip et al.
JOURNAL OF NEUROINFLAMMATION (2019)
ApoE attenuates unresolvable inflammation by complex formation with activated C1q
Changjun Yin et al.
NATURE MEDICINE (2019)
Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model
Mario Merlini et al.
NEURON (2019)
Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Evangeline M. Foster et al.
FRONTIERS IN NEUROSCIENCE (2019)
Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders
Ela Bar et al.
GLIA (2019)
Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1
Hanadie Yousef et al.
NATURE MEDICINE (2019)
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury
Giuseppe Castellano et al.
AGING-US (2019)
Single-cell analysis reveals T cell infiltration in old neurogenic niches
Ben W. Dulken et al.
NATURE (2019)
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Ana Griciuc et al.
NEURON (2019)
The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy
Yu Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy
Tiffany Wu et al.
CELL REPORTS (2019)
100th Anniversary of Jules Bordet's Nobel Prize: Tribute to a Founding Father of Immunology
Jean-Marc Cavaillon et al.
FRONTIERS IN IMMUNOLOGY (2019)
Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
Jean-Vianney Haure-Mirande et al.
MOLECULAR PSYCHIATRY (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
New insights into the immune functions of complement
Edimara S. Reis et al.
NATURE REVIEWS IMMUNOLOGY (2019)
The renaissance of complement therapeutics
Daniel Ricklin et al.
NATURE REVIEWS NEPHROLOGY (2018)
Interleukin 6 and complement serum level study in Parkinson's disease
Branislav Vesely et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Blood-brain barrier (BBB) and the complement landscape
Jessy J. Alexander
MOLECULAR IMMUNOLOGY (2018)
Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice
Ali Alawieh et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain
Matthew M. Boisvert et al.
CELL REPORTS (2018)
Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects
Zhouwei Xu et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2018)
Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals Findings From the Harvard Aging Brain Study
Jennifer S. Rabin et al.
JAMA NEUROLOGY (2018)
Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway
Liyan Hou et al.
REDOX BIOLOGY (2018)
Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Alejandra Bosco et al.
MOLECULAR THERAPY (2018)
Inflammaging: a new immune-metabolic viewpoint for age-related diseases
Claudio Franceschi et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease
Alexandra Litvinchuk et al.
NEURON (2018)
Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis
Jun Zhang et al.
BMC OPHTHALMOLOGY (2018)
Monogenic Lupus: A Developing Paradigm of Disease
Jessie M. Alperin et al.
FRONTIERS IN IMMUNOLOGY (2018)
The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes
Szilvia Lukacsi et al.
IMMUNOLOGY LETTERS (2017)
Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse
Katharina M. Quell et al.
JOURNAL OF IMMUNOLOGY (2017)
Inflammaging and human longevity in the omics era
Daniela Monti et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2017)
The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment
Maartje J. Geerlings et al.
MOLECULAR IMMUNOLOGY (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Qiaoqiao Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Phenotype Characteristics of Patients With Age-Related Macular Degeneration Carrying a Rare Variant in the Complement Factor H Gene
Eveline Kersten et al.
JAMA OPHTHALMOLOGY (2017)
The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration
Maartje J. Geerlings et al.
JAMA OPHTHALMOLOGY (2017)
Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Yiting Liu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey
Eli Shobin et al.
GEROSCIENCE (2017)
Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
Myoungsun Son et al.
SCIENTIFIC REPORTS (2017)
Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss
Sheri L. Peterson et al.
SCIENTIFIC REPORTS (2017)
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology
Jean-Vianney Haure-Mirande et al.
ACTA NEUROPATHOLOGICA (2017)
A novel microglial subset plays a key role in myelinogenesis in developing brain
Agnieszka Wlodarczyk et al.
EMBO JOURNAL (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis
John D. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis
Adrienne Boire et al.
CELL (2017)
Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury
Rodney M. Ritzel et al.
JOURNAL OF IMMUNOLOGY (2016)
Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain
Fengjiao Wu et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
Hong Lian et al.
JOURNAL OF NEUROSCIENCE (2016)
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
Giuseppina Arbore et al.
SCIENCE (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
Increased internalization of complement inhibitor CD59 may contribute to endothelial inflammation in obstructive sleep apnea
Memet Emin et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration
Judith Lechner et al.
IMMUNITY & AGEING (2016)
Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function
Maria I. Fonseca et al.
PLOS ONE (2016)
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Janelle Drouin-Ouellet et al.
ANNALS OF NEUROLOGY (2015)
Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline
Qiaoqiao Shi et al.
JOURNAL OF NEUROSCIENCE (2015)
Complement Protein C1q Modulates Neurite Outgrowth In Vitro and Spinal Cord Axon Regeneration In Vivo
Sheri L. Peterson et al.
JOURNAL OF NEUROSCIENCE (2015)
C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease
Ling Li et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Complement, a target for therapy in inflammatory and degenerative diseases
B. Paul Morgan et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vascular parkinsonism-characteristics, pathogenesis and treatment
Amos D. Korczyn
NATURE REVIEWS NEUROLOGY (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer's Disease
Hong Lian et al.
NEURON (2015)
Plasma Clusterin and Lipid Profile: A Link with Aging and Cardiovascular Diseases in a Population with a Consistent Number of Centenarians
Angela Baralla et al.
PLOS ONE (2015)
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
Douglas G. Walker et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Candidate Pathway-Based Genome-Wide Association Studies Identify Novel Associations of Genomic Variants in the Complement System Associated With Coronary Artery Disease
Chengqi Xu et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood
S. Mantovani et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Claudio Franceschi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Role for terminal complement activation in amyotrophic lateral sclerosis disease progression
Trent M. Woodruff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The TLQP-21 Peptide Activates the G-Protein-Coupled Receptor C3aR1 via a Folding-upon-Binding Mechanism
Cheryl Cero et al.
STRUCTURE (2014)
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Alasdair Warwick et al.
JOURNAL OF CLINICAL MEDICINE (2014)
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
Gillian Ingram et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Complement - tapping into new sites and effector systems
Martin Kolev et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Ethan A. Winkler et al.
ACTA NEUROPATHOLOGICA (2013)
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease
Bin Zhang et al.
CELL (2013)
Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells
Sebastien Hannedouche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis
John D. Lee et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2013)
A Dramatic Increase of C1q Protein in the CNS during Normal Aging
Alexander H. Stephan et al.
JOURNAL OF NEUROSCIENCE (2013)
Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Guo Zhang et al.
NATURE (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice
Christian S. Lobsiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging
Kuti Baruch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Alexander H. Stephan et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study
David H. Cribbs et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Genetic Deficiency of Complement Component 3 does not Alter Disease Progression in a Mouse Model of Huntington's Disease
Paul B. Larkin et al.
JOURNAL OF HUNTINGTONS DISEASE (2012)
Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice
Helga D. Manthey et al.
FASEB JOURNAL (2011)
Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma
Gareth R. Howell et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease
Candan Depboylu et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Complement in the brain
Robert Veerhuis et al.
MOLECULAR IMMUNOLOGY (2011)
Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation
M. Sta et al.
NEUROBIOLOGY OF DISEASE (2011)
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients
P. Annunziata et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
Madhav Thambisetty et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
C5a Receptor Targeting in Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice
Erdenechimeg Shagdarsuren et al.
CIRCULATION (2010)
Complement Component C5a Activates ICAM-1 Expression on Human Choroidal Endothelial Cells
Jessica M. Skeie et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Complement and immune defense: From innate immunity to human diseases
Peter F. Zipfel
IMMUNOLOGY LETTERS (2009)
Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease
Maria I. Fonseca et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
Isaac M. Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Complement regulators and inhibitory proteins
Peter F. Zipfel et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Inflammaging as a prodrome to Alzheimer's disease
Brian Giunta et al.
JOURNAL OF NEUROINFLAMMATION (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
Riina Oksjoki et al.
ATHEROSCLEROSIS (2007)
Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity
Yajie Liang et al.
BRAIN RESEARCH (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice
Vinay K. Bhatia et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
Claudio Franceschi et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
David A. Loeffler et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Transcriptional profiling of aging in human muscle reveals a common aging signature
Jacob M. Zahn et al.
PLOS GENETICS (2006)
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Trent M. Woodruff et al.
FASEB JOURNAL (2006)
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury
Iris Leinhase et al.
EXPERIMENTAL NEUROLOGY (2006)
Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain
JA Duce et al.
NEUROBIOLOGY OF AGING (2006)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
Inflammation, the complement system and the diseases of aging
EG McGeer et al.
NEUROBIOLOGY OF AGING (2005)
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis
WS Speidl et al.
EUROPEAN HEART JOURNAL (2005)
C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis
F Niculescu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2004)
Neuronal localization of C1q in preclinical Alzheimer's disease
MI Fonseca et al.
NEUROBIOLOGY OF DISEASE (2004)
Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice
L Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist
DL Sewell et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction - The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
CB Granger et al.
CIRCULATION (2003)
Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells
T Monsinjon et al.
FASEB JOURNAL (2003)
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
S Sayah et al.
MOLECULAR BRAIN RESEARCH (2003)
Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages
F Reichert et al.
NEUROBIOLOGY OF DISEASE (2003)
Complement C3a and C5a induce different signal transduction cascades in endothelial cells
IU Schraufstatter et al.
JOURNAL OF IMMUNOLOGY (2002)
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
ME Rosenberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
K Yasojima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse
J Van Beek et al.
EXPERIMENTAL NEUROLOGY (2000)
C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion
MA Jagels et al.
IMMUNOPHARMACOLOGY (2000)
分享论文
